Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on November 6, 2003

Stroke. 2003
Published online before print November 6, 2003, doi: 10.1161/01.STR.0000098004.26252.EB
A more recent version of this article appeared on December 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/12/2822    most recent
01.STR.0000098004.26252.EBv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoekstra, T.
Right arrow Articles by Schouten, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoekstra, T.
Right arrow Articles by Schouten, E. G.
Related Collections
Right arrow Fibrinolysis
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction
Right arrow Genetics of Stroke
Right arrow Risk Factors for Stroke
Right arrow Epidemiology
Right arrow Transient Ischemic Attacks
Right arrow Genetics of cardiovascular disease

Submitted on June 18, 2003
Accepted on July 18, 2003

4G/4G Genotype of PAI-1 Gene Is Associated With Reduced Risk of Stroke in Elderly

Tiny Hoekstra PhD; Johanna M. Geleijnse PhD*; Cornelis Kluft PhD; Erik J. Giltay PhD; Frans J. Kok PhD; and Evert G. Schouten PhD

From the Division of Human Nutrition, Wageningen University, Wageningen (T.H., J.M.G., E.J.G., F.J.K., E.G.S.), and Gaubius Laboratory, TNO Prevention and Health, Leiden (C.K.), Netherlands.

* To whom correspondence should be addressed. E-mail: Marianne.Geleijnse{at}wur.nl.

Background and Purpose--Plasminogen activator inhibitor type 1 (PAI-1) is the main inhibitor of fibrinolysis, and high levels may increase the risk of cardiovascular disease. The 4G/5G polymorphism affects PAI-1 gene transcription with lower levels of plasma PAI-1 in the presence of the 5G allele. We investigated whether plasma PAI-1 and 4G/5G genotype would predict the occurrence of cardiovascular events at old age.

Methods--Relative risks for cardiovascular events and all-cause mortality were obtained in strata of PAI-1 activity and 4G/5G genotype in a population-based study of 637 Dutch elderly with 7.8 years of follow-up.

Results--The 4G/4G genotype was associated with a decreased risk of stroke (relative risk [RR]=0.4; 95% CI, 0.2 to 0.9), transient ischemic attack (RR=0.3; 95% CI, 0.1 to 0.8), and cardiovascular mortality (RR=0.5; 95% CI, 0.3 to 1.0) after adjustment for age, sex, and time of blood sampling. 4G carriers had an increased risk of myocardial infarction, but this was not statistically significant. Subjects with high plasma PAI-1 activity were at increased risk of stroke (RR=3.3 in highest versus lowest tertile; 95% CI, 1.5 to 7.1), cardiovascular mortality (RR=2.3; 95% CI, 1.2 to 4.4), and all-cause mortality (RR=1.5; 95% CI, 1.1 to 2.1).

Conclusions--Our results provide support for a protective effect of the 4G allele against stroke, which is notable given the direct relationship between stroke and PAI-1 activity. We hypothesize that a local increase in tissue PAI-1 associated with the 4G allele may stabilize plaques, thereby reducing the risk of cerebrovascular disease.


Key words: cerebral ischemia, transient • cerebrovascular accident • fibrinolysis • polymorphism




This article has been cited by other articles:


Home page
StrokeHome page
K. Jood, P. Ladenvall, A. Tjarnlund-Wolf, C. Ladenvall, M. Andersson, S. Nilsson, C. Blomstrand, and C. Jern
Fibrinolytic Gene Polymorphism and Ischemic Stroke
Stroke, October 1, 2005; 36(10): 2077 - 2081.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P.-G. Wiklund, L. Nilsson, S. N. Ardnor, P. Eriksson, L. Johansson, B. Stegmayr, A. Hamsten, D. Holmberg, and K. Asplund
Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke: Replicated Findings in Two Nested Case-Control Studies Based on Independent Cohorts
Stroke, August 1, 2005; 36(8): 1661 - 1665.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. E. Arking, G. Atzmon, A. Arking, N. Barzilai, and H. C. Dietz
Association Between a Functional Variant of the KLOTHO Gene and High-Density Lipoprotein Cholesterol, Blood Pressure, Stroke, and Longevity
Circ. Res., March 4, 2005; 96(4): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Roest and J. D. Banga
Editorial Comment-- Genetic Make-Up for Increased PAI-1 Expression Protects Against Stroke
Stroke, December 1, 2003; 34(12): 2828 - 2829.
[Full Text] [PDF]